Calcium kinetic studies in patients on CAPD: Improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover

Peritoneal Dialysis International

Volumn 17, Issue 1, 1997, Pages 59-65

  Kurz, Peter ^a   Tsobanelis, Theoharis ^a   Brunkhorst, Reinhard ^b   Roth, Paul ^c   Werner, Eckhard ^c   Schoeppe, Wilhelm ^d   Vlachojannis, Jannis ^e  

^a KfH Dialysezentrum   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e Rion University Hospital   (Greece)

Author keywords

Calcium turnover; Secondary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM 45; CALCIUM 47; CALCIUM ION; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; TRACER; VITAMIN D;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DISEASE; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; FEMALE; HUMAN; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL;

EID: 0030707737     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700113     Document Type: Article

References (20)

1. Shusterman NH, Wasserstein AG, Morrison G, Audet P, Fallon MD, Kaplan F. Controlled study on renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. Am J Med 1987; 82:1148-56.
2. Kurz P, Tsobanelis T, Roth P, et al. Differences in calcium kinetic pattern between CAPD and HD patients. Clin Nephrol 1995; 44:255-61.
3. Gokal R, Ramos JM, Ellis HA, et al. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1983; 23:15-21.
4. Zucchelli P, Catizone L, Casanova S, Fusaroli M, Fabrri L, Ferrari G. Renal osteodystrophy in CAPD patients. Miner Electrolyte Metab 1984; 10:326-32.
5. Coburn JW. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Kidney Int 1993; 43(Suppl):S92-100.
6. Buccianti G, Bianchi ML, Valenti G. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Clin Nephrol 1984; 22:279-83.
7. Malluche HH, Moniere-Faugere M-C. Risk of adynamic bone disease in dialyzed patients. Kidney Int 1992; 42(Suppl):S62-7.
8. Sherrard DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 1993; 43:436-42.
9. Kurz P, Monier-Faugere M-C, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46:855-61.
10. Delmez JA, Dougan CS, Gearing BK, et al. The effects of intraperitoneal calcitriol on calcium and parathyroid hormone. Kidney Int 1987; 31:795-9.
11. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. New Engl J Med 1989; 321:274-9.
12. Hutchison AJ, Merchant M, Boulton HF, Hinchcliffe R, Gokal R. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid. Perit Dial Int 1993; 13:219-23.
13. Malluche HH, Matthews C, Faugere M-C, Fanti P, Endres DB, Friedler RM. 1,25-dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology 1986; 119:1298-304.
14. Ruedin P, Rizzoli R, Slosman D, Leski, Bonjour J-P. Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure. Kidney Int 1994; 45:245-52.
15. Delmez JA, Fallon MD, Bergfeld MA, Gearing BK, Dougan CS, Teitelbaum SL. Continuous ambulatory peritoneal dialysis and bone. Kidney Int 1986; 30:379-84.
16. Quarles LD, Davidai GA, Schwab SJ, Bartholomay DW, Lobaugh B. Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism. Kidney Int 1988; 34:840-4.
17. Teitelbaum SL, Bergfeld MA, Freitag J, Hruska KA, Slatopolsky E. Do parathyroid hormone and 1,25-dihydroxyvitamin D modulate bone formation in uremia? J Clin Endocrinol Metab 1980; 51:247-51.
18. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segere GV, Goodman WG. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 1994; 45:253-8.
19. Delmez JA. The spectrum of renal osteodystrophy in peritoneal dialysis patients. Pent Dial Int 1996; 16:24-5.
20. Quanle QI, Monier-Faugere M-C, Zhaopo G, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995; 26:622-31.